Fundraising Fox

ACTO

5 known investors

actoapp.com ↗

ACTO offers an AI-powered platform for life sciences field teams, unifying training, coaching, certification, and practice to prepare sales reps and medical science liaisons for engaging healthcare professionals. It provides role-based AI "SuperAgents" that automate workflows and support commercial, medical, and product launch success in the biopharma and medical device sectors.

AI & Machine LearningEdTechHealthtech

Founders & leadership

PK
Parth KhannaCEO

Investors · 5

DMZToronto
Panache VenturesMontreal · $1.5M
MaRS Investment Accelerator FundreportedToronto
Questa CapitalreportedSan Francisco · $15M – $40M
Salesforce VenturesreportedSan Francisco · $5M – $50M

In the news

ACTO Raises $18 Million in Series B | The SaaS Newsthesaasnews.com · Jul 2022ACTO secures $23.5 million CAD as pandemic tailwinds increase demand for life sciences education | BetaKitbetakit.com · Jul 2022ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences | ACTOacto.com · Jul 2022

Frequently asked questions

What does ACTO do?
ACTO offers an AI-powered platform for life sciences field teams, unifying training, coaching, certification, and practice to prepare sales reps and medical science liaisons for engaging healthcare professionals. It provides role-based AI "SuperAgents" that automate workflows and support commercial, medical, and product launch success in the biopharma and medical device sectors.
Who are ACTO's investors?
ACTO's investors include DMZ, Panache Ventures, MaRS Investment Accelerator Fund, Questa Capital, Salesforce Ventures.